News The Lancet: Findings from a Phase I study completed by Altasciences and Novo Nordisk A/S to determine the safety, tolerability, pharmacokinetic, and pharmacodynamics of a drug combination for weight management Apr 28, 2021
News BioPharma Dive: Altasciences' Comprehensive Integrated Solution for Clinical Supply Manufacture Dec 7, 2020
News BioPharma Dive: Ligand Binding Program Considerations — The Value of Preclinical to Clinical Bioanalytical Expertise Nov 16, 2020
News Sickle Cell Disease News: Phase I Trial of Oral FTX-6058 to Promote Fetal Hemoglobin Set to Open Oct 27, 2020
News Fierce Biotech: Altasciences Continues to Beef Up its Exec Suite With Newly Appointed CMO Jun 9, 2020